SmartPharm Therapeutics
Cambridge
About SmartPharm Therapeutics
SmartPharm Therapeutics is a second-generation gene-encoded therapeutics company that has benefited from the first decades of learning in gene therapy development to produce an evolved therapeutic platform. They integrate these insights with key technologies and engineering capabilities to enable them to produce optimal gene-encoded therapeutics for patients. SmartPharm is focused on “gene-encoded therapeutics”. It is a subset of gene therapy that seeks to insert nucleic acids (mRNA or DNA) into cells to make normal versions of a missing or abnormal program or to produce an entirely new type of protein that has therapeutic benefit.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $10.5M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2018)
- Website: smartpharmtx.com
- Phone: +1.857.327.8740
Industries & Categories
Biopharma, Biotechnology, Developer Platform, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/smartpharm-therapeutics-71448 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.